GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NWBO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Northwest Biotherapeutics stock price took a fall of -5.88% on Friday
(Updated on Apr 19, 2024)

Sell candidate since Apr 04, 2024 Loss -11.96% PDF

The Northwest Biotherapeutics stock price fell by -5.88% on the last day (Friday, 19th Apr 2024) from $0.510 to $0.480. During the last trading day the stock fluctuated 8.33% from a day low at $0.480 to a day high of $0.520. The price has fallen in 7 of the last 10 days and is down by -11.41% for this period. Volume has increased on the last day by 554 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $805.51 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.41% during the next 3 months and, with a 90% probability hold a price between $0.395 and $0.500 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NWBO Signals & Forecast

There are few to no technical positive signals at the moment. The Northwest Biotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.505 and $0.532. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -20.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Northwest Biotherapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Northwest Biotherapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0400 between high and low, or 8.33%. For the last week, the stock has had daily average volatility of 6.04%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NWBO) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Northwest Biotherapeutics to open at $0.493, and during the day (based on 14 day Average True Range), to move between $0.443 and $0.517, which gives a possible trading interval of +/-$0.0374 (+/-7.80%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 15.59% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.519, some $0.0390 (8.13%) from the current price of $0.480, our system finds the risk reward not very attractive.

Is Northwest Biotherapeutics stock A Buy?

Northwest Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -6.189 Strong Sell Candidate Downgraded

Predicted Opening Price for Northwest Biotherapeutics of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$0.493 ( 2.78%) $0.480

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NWBO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.533 11.11 %
R2 0.518 7.93 %
R1 0.509 5.96 %
Current price: 0.480
Support S1 0.478 -0.406 %
S2 0.469 -2.37 %
S3 0.453 -5.56 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.572 19.06 %
R2 0.550 14.58 %
R1 0.519 8.13 %
Current price 0.480
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Northwest Biotherapeutics Stock and on which exchange is it traded?
The symbol for Northwest Biotherapeutics is NWBO and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Northwest Biotherapeutics Stock?
Northwest Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Northwest Biotherapeutics Stock?
Northwest Biotherapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Northwest Biotherapeutics Stock.

What's the current price of Northwest Biotherapeutics Stock?
As of the end of day on the 2024-04-19, the price of an Northwest Biotherapeutics (NWBO) share was $0.480.

What is the 52-week high and low for Northwest Biotherapeutics Stock?
The 52-week high for Northwest Biotherapeutics Stock is $1.09 and the 52-week low is $0.400.

What is the market capitalization of Northwest Biotherapeutics Stock?
As of the 2024-04-19, the market capitalization of Northwest Biotherapeutics is 571.186M.

When is the next earnings date for Northwest Biotherapeutics?
The upcoming earnings date for Northwest Biotherapeutics is May 08, 2024.
Click to get the best stock tips daily for free!

About Northwest Biotherapeutics

Northwest Biotherapeutics Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company ... NWBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT